Schedule 13D ownership disclosure
MEREO BIOPHARMA GROUP PLC
Security class unavailable · CUSIP: 589492107
Event date: 2022-10-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 13.4100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-112342
- Form type
- SC 13D
- Filer
- Mereo BioPharma Group plc
- CIK
- CIK 1719714
- Filed
- Oct 28, 2022
- Reporting period
- Oct 28, 2022
- Description
- Schedule 13D beneficial ownership